Actively Recruiting
What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Led by Chinese University of Hong Kong · Updated on 2023-09-01
50
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Various to-be-discard material from IVF treatment cycle will be collect and examined, aiming to identify potential reasons of successful outcome or cycle failure.
CONDITIONS
Official Title
What To-be-discard Biomaterials From ART Cycles Can Tell us About the Treatment Cycle Outcome?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients attending the Assisted Reproductive Technology (ART) Unit of the Chinese University of Hong Kong for ART treatment.
- Participant able to give voluntary, written, informed consent to participate in the study.
You will not qualify if you...
- Patient using donor gamete in IVF treatment
- Patient refuses to join and failed to giving consent for any reasons
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Chinese University of Hong Kong and Prince of Wales Hospital
Hong Kong, Hong Kong
Actively Recruiting
Research Team
Y
Yiu Leung D Chan, DPhil
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here